Date of event
Continuing Education Credits
Who Attends The Liver Meeting®
The Liver Meeting® brings together 9,500 attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field. Our attendees include those focused on:
- Adult and pediatric hepatology
- Clinical, basic and translational researchers
- Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, pathologists, anesthesiologists and radiologists
- Primary care physicians
- NPs, PAs, RNs, pharmacists and other allied health professionals
- Trainees and students in all disciplines listed above
Registration and Registration Packages
Information about registration and the registration packages for The Liver Meeting Digital Experience™ will be available Late Summer 2020.
The Liver Meeting® is the premier Annual Meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments and the results from pilot and multicenter studies. Approximately 10 percent of Americans have some form of liver disease, but fortunately, the research community has made great strides in recent years in developing new treatments for patients.
The American Association for the Study of Liver Diseases appreciates your interest in covering The Liver Meeting Digital Experience™ and is happy to provide credentialed media with complimentary media registration. Registration for media will open in late Summer 2020. More information to come.
Below you will find a complete listing of the eligibility requirements, guidelines and policies for members of the media who wish to attend The Liver Meeting Digital Experience™. Read all of the sections below carefully, as there have been updates to our policies.
- The digital Newsroom is open to credentialed media representatives only. All journalists are encouraged to pre-register by November 10.
- AASLD does not share media lists.
Accepted abstracts are made available to the public on the AASLD website in early October, and are published in the October supplement of HEPATOLOGY. Late-breaking abstracts will be available in mid-October (more information to come), and are published in the December issue of HEPATOLOGY. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website. Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until 8:00 am ET Friday, November 13.
Information released prior to this day is a violation of the AASLD Abstract Embargo Policy and the abstract is subject to withdrawal from The Liver Meeting Digital Experience™ program. Authors are responsible for notifying financial and other sponsors about this policy.
AASLD may allow for exceptions, on a case-by-case basis, to the Abstract Embargo Policy for compelled disclosures mandated by federal securities laws. However, AASLD requires the company President, General Counsel, or other appropriate official of a company seeking such an exception to attest in writing to the specific facts in support of the request, including exactly how the securities laws are implicated, with statutory citation(s). General statements of the need to comply with the law will not be considered sufficient. Requests for an exception must be sent to AASLD. AASLD requires a minimum of five (5) days from receipt of the request to evaluate the request. In granting an exception, AASLD requires the company to state in their public disclosure that the complete and final results will be presented at The Liver Meeting Digital Experience™. AASLD will also require the inclusion of unreleased and unique data in such a presentation at The Liver Meeting Digital Experience™.
Public release of a journal article relevant to the abstract will be considered an exception to the Embargo Policy if at the time of the abstract submission deadline, the decision concerning the manuscript had not been revealed to the authors.
Journalists and contributing freelancers, employed by a recognized news organization, are eligible to apply for media registration. To be eligible for registration, media in all categories must be directly involved in the creation of news content for organizations that meet these criteria:
- Publish original editorial news coverage in a regular news section
- Have complete editorial freedom from advertisers, funders and/or sponsors
- If sponsored, the outlet has multiple sponsors (no single-sponsored publications)
- Advertisers, sponsors, paid editorial, and other funding sources are clearly identified
Bloggers will receive press credentials on a case-by-case basis. Please include a link to recent liver disease, hepatology or health care science coverage with your registration for credentials. Finally, all blogs must demonstrate the dissemination of original, editorial news coverage and editorial freedom from advertisers and/or sponsors (single-sponsored blogs will not receive credentials; blogs with advertising must have multiple advertisers clearly identified).
Photographers, videographers, and/or other members of the multimedia team accompanying credentialed news outlets may register as media and provide a link to recent coverage from their team. Further credentialing may be required during the approval process.
NOTE: AASLD has the right to inspect the credentials of anyone registering as media and reserves the right to refuse to register any individual as press.
The following individuals are not eligible for press registration or access to the digital Newsroom.
- Individuals who receive exhibitor passes
- Publishers or a publication's advertising, marketing, public relations, sales, circulation, or any other non-editorial representatives
- Industry/exhibitor press officers and their public relations consultants
- Financial or business analysts
- Educational program developers (including CME writers and editors)
- Trade media management personnel
- Editors, writers, and scientific advisory board members for journals that do not have editorial news sections
- Companies or organizations producing publications, videos, and/or other electronic media intended for internal use, marketing, advertising, financial analysis, or public relations purposes
- Media which produce a communications vehicle that is sponsored by a single organization or whose revenue for the publication or issue of a publication depends solely on coverage of The Liver Meeting Digital Experience™
- Media which produce a communications vehicle that uses the AASLD’s name or logo, or The Liver Meeting® or The Liver Meeting Digital Experience™ name/logo to imply endorsement from AASLD
NOTE: AASLD prohibits the development of CME content based on information presented at its meetings. CME writers and editors, and those writers and editors working on behalf of organizations that have written CME based on AASLD meetings, are not eligible for press passes.
- Sales, marketing or representing a company for the purposes of obtaining advertising, subscriptions, selling photography/video production, or other products or services from any registrant or exhibitor
- Misrepresentation of role or activities to obtain media registration
- Sharing or distributing embargoed materials prior to the end of the embargo
- Developing or assisting in the development of CME programs
- Soliciting presenters and/or attendees for inclusion in CME programs
- Publishing or posting presentation slides, live streams of meeting presentations, or sharing copyrighted meeting materials without written permission. See copyright policy in the tab below for more information.
AASLD will hold two press conferences highlighting select research coming out of The Liver Meeting Digital Experience™. These press conferences are an opportunity for invited investigators to share their findings with members of the media. Press releases will be sent to registered press under an embargo prior to the start of the meeting.
Press conferences are not open to the public; however, one representative from each company may attend the press conference. Company representatives must be approved by the AASLD Media Team prior to the start of the conference and must remain silent through the duration of the conference (i.e., no asking or responding to questions).
Press Conference Slate
Will be announced in October 2020.
Credentialed media have access to all general sessions, the exhibit hall and poster area, the Postgraduate Course and the Basic Science Symposium. Access to pre-conference and other ticketed events with limited enrollment are restricted to ticket holders only. Press wishing to attend these events are encouraged to purchase a ticket.
Recording The Liver Meeting Digital Experience™ exhibit spaces and e-posters is prohibited.
Under no circumstances may presentations be rebroadcasted.
Any images from the Meeting should be credited to The Liver Meeting Digital Experience™ 2020.
Reproduction of materials such as abstract data, posters, presentation slides, etc. requires obtaining permission from the listed author(s) and/or presenter(s) as well as from any individual or group that may hold copyright on the material.
Requests to reproduce excerpts of abstracts or poster presentations must be through the publisher. These requests should be addressed to firstname.lastname@example.org.
Journalists violating copyright may have their press credentials denied the following year.
Insignias and logos of the AASLD, The Liver Meeting®, The Liver Meeting Digital Experience™, or AASLD Foundation are proprietary marks. Use of these in any fashion, by any entity, for any purpose, is prohibited without the written permission of AASLD. The use of insignias, logos and images that mislead the intended audience to believe that a piece or production is coming from the AASLD is strictly prohibited and will result in the denial of press credentials for future meetings.
If you intend to present coverage of The Liver Meeting Digital Experience™ in a dedicated website or newsletter, please include the following disclaimer at the top of your piece: This information is brought to you by [insert organization name] and is not sponsored by, nor a part of, the American Association for the Study of Liver Diseases or The Liver Meeting® or The Liver Meeting Digital Experience™. Additionally, you may not use the AASLD or The Liver Meeting® or The Liver Meeting Digital Experience™ logos or name to imply affiliation.
AASLD reserves the right to request promotional activities violating this policy be edited or removed. Failure to comply with these guidelines may result in loss of press credentials for future meetings.
- The digital Newsroom is open to credentialed media representatives only. Exhibitors and public relations professionals will not be granted access to the digital Newsroom.
- All exhibitors are expected to comply with all rules and regulations set forth by AASLD and The Liver Meeting Digital Experience™.
- All exhibitors are expected to comply with all rules and regulations set forth by AASLD and The Liver Meeting®.
- AASLD does not share media lists. Media which traditionally cover The Liver Meeting® include trade and consumer media, international and US.
- AASLD will not display exhibitor press materials on the digital Newsroom page. Press materials on research presented during the meeting must be given attribution to The Liver Meeting Digital Experience™ 2020. NOTE: AASLD does not review/approve press materials. Exhibitors are responsible for reviewing and adhering to the Embargo Policy (found in the tab above) and should refrain from using the AASLD logo, The Liver Meeting® logo, The Liver Meeting Digital Experience™ logo, and should not imply endorsement from AASLD.
- Press conferences held by exhibitors or other groups (outside of AASLD’s official press conference) are considered "outside press conferences" and must be held outside of official meeting hours; groups are responsible for securing their own space. Please see affiliate meetings rules and regulations.
- Outside press conferences may not be promoted in the digital Newsroom.
- Groups planning to hold press conferences must register their conferences with Nola Gruneisen at email@example.com and include the following information: Date, time, location and topic of press conference.